Tags

Type your tag names separated by a space and hit enter

Pathogenesis of renal failure in multiple myeloma: any role of contrast media?
Biomed Res Int 2014; 2014:167125BR

Abstract

The spectrum of kidney disease-associated monoclonal immunoglobulin and plasma cell malignancies is remarkably broad and encompasses nearly all nephropathologic entities. Multiple myeloma with kidney impairment at presentation is a medical emergency since the recovery of kidney function is associated with survival benefits. In most cases, kidney impairment may be the first clinical manifestation of malignant plasma cell dyscrasias like multiple myeloma and light chain amyloidosis. Multiple myeloma per se cannot be considered a main risk factor for developing acute kidney injury following intravascular administration of iodinated contrast media. The risk is increased by comorbidities such as chronic kidney disease, diabetes, hypercalcemia, dehydration, and use of nephrotoxic drugs. Before the administration of contrast media, the current recommended laboratory tests for assessing kidney function are serum creatinine measurement and the estimation of glomerular filtration rate by using the CKD-EPI equation. The assessment of Bence Jones proteinuria is unnecessary for evaluating the risk of kidney failure in patients with multiple myeloma, since this test cannot be considered a surrogate biomarker of kidney function.

Authors+Show Affiliations

Laboratory Medicine Service, IRCCS AOU San Martino-IST, National Institute for Cancer Research, University-Hospital San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy.Amyloidosis Research and Treatment Center, Clinical Chemistry Laboratories, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy ; Department of Molecular Medicine, University of Pavia, Italy.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

24877060

Citation

Mussap, Michele, and Giampaolo Merlini. "Pathogenesis of Renal Failure in Multiple Myeloma: Any Role of Contrast Media?" BioMed Research International, vol. 2014, 2014, p. 167125.
Mussap M, Merlini G. Pathogenesis of renal failure in multiple myeloma: any role of contrast media? Biomed Res Int. 2014;2014:167125.
Mussap, M., & Merlini, G. (2014). Pathogenesis of renal failure in multiple myeloma: any role of contrast media? BioMed Research International, 2014, p. 167125. doi:10.1155/2014/167125.
Mussap M, Merlini G. Pathogenesis of Renal Failure in Multiple Myeloma: Any Role of Contrast Media. Biomed Res Int. 2014;2014:167125. PubMed PMID: 24877060.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pathogenesis of renal failure in multiple myeloma: any role of contrast media? AU - Mussap,Michele, AU - Merlini,Giampaolo, Y1 - 2014/04/30/ PY - 2013/11/01/received PY - 2014/03/13/revised PY - 2014/03/13/accepted PY - 2014/5/31/entrez PY - 2014/5/31/pubmed PY - 2015/2/13/medline SP - 167125 EP - 167125 JF - BioMed research international JO - Biomed Res Int VL - 2014 N2 - The spectrum of kidney disease-associated monoclonal immunoglobulin and plasma cell malignancies is remarkably broad and encompasses nearly all nephropathologic entities. Multiple myeloma with kidney impairment at presentation is a medical emergency since the recovery of kidney function is associated with survival benefits. In most cases, kidney impairment may be the first clinical manifestation of malignant plasma cell dyscrasias like multiple myeloma and light chain amyloidosis. Multiple myeloma per se cannot be considered a main risk factor for developing acute kidney injury following intravascular administration of iodinated contrast media. The risk is increased by comorbidities such as chronic kidney disease, diabetes, hypercalcemia, dehydration, and use of nephrotoxic drugs. Before the administration of contrast media, the current recommended laboratory tests for assessing kidney function are serum creatinine measurement and the estimation of glomerular filtration rate by using the CKD-EPI equation. The assessment of Bence Jones proteinuria is unnecessary for evaluating the risk of kidney failure in patients with multiple myeloma, since this test cannot be considered a surrogate biomarker of kidney function. SN - 2314-6141 UR - https://www.unboundmedicine.com/medline/citation/24877060/Pathogenesis_of_renal_failure_in_multiple_myeloma:_any_role_of_contrast_media L2 - https://dx.doi.org/10.1155/2014/167125 DB - PRIME DP - Unbound Medicine ER -